BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 32150689)

  • 1. Identification of Potential Diagnostic and Prognostic Values of
    Li M; Wu F; Zheng Q; Wu Y; Wu Y
    DNA Cell Biol; 2020 May; 39(5):909-917. PubMed ID: 32150689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High P4HA1 expression is an independent prognostic factor for poor overall survival and recurrent-free survival in head and neck squamous cell carcinoma.
    Li Q; Shen Z; Wu Z; Shen Y; Deng H; Zhou C; Liu H
    J Clin Lab Anal; 2020 Mar; 34(3):e23107. PubMed ID: 31782831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of P4HA1 as a prognostic biomarker for high-grade gliomas.
    Hu WM; Zhang J; Sun SX; Xi SY; Chen ZJ; Jiang XB; Lin FH; Chen ZH; Chen YS; Wang J; Yang QY; Guo CC; Mou YG; Chen ZP; Zeng J; Sai K
    Pathol Res Pract; 2017 Nov; 213(11):1365-1369. PubMed ID: 28964577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of P4HA1 Is Correlated with Poor Survival and Immune Infiltrates in Lung Adenocarcinoma.
    Zhou H; He Y; Li L; Wu C; Hu G
    Biomed Res Int; 2020; 2020():8024138. PubMed ID: 33299876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic and diagnostic roles of prolyl 4-hydroxylase subunit α members in breast cancer.
    Li M; Wang Q; Zheng Q; Wu L; Zhao B; Wu Y
    Biomark Med; 2021 Sep; 15(13):1085-1095. PubMed ID: 34387118
    [No Abstract]   [Full Text] [Related]  

  • 6. Comprehensive Analysis of Gene Expression Profiles Identifies a
    Chen Z; Chen M; Xue Z; Zhu X
    Cancer Biother Radiopharm; 2021 Oct; 36(8):693-704. PubMed ID: 34520234
    [No Abstract]   [Full Text] [Related]  

  • 7. Systematic Analysis of the Expression and Prognostic Significance of P4HA1 in Pancreatic Cancer and Construction of a lncRNA-miRNA-P4HA1 Regulatory Axis.
    Hu Z; Song F; Hu Y; Liao T
    Biomed Res Int; 2020; 2020():8877334. PubMed ID: 33415167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. P4HA1 expression and function in esophageal squamous cell carcinoma.
    Gou W; Song B; Yang Y
    Medicine (Baltimore); 2023 Dec; 102(51):e36800. PubMed ID: 38134053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. P4HA1/HIF1α feedback loop drives the glycolytic and malignant phenotypes of pancreatic cancer.
    Cao XP; Cao Y; Li WJ; Zhang HH; Zhu ZM
    Biochem Biophys Res Commun; 2019 Aug; 516(3):606-612. PubMed ID: 31239153
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Sato K; Sano D; Takahashi H; Kuwahara T; Aizawa Y; Aoyama J; Nojima Y; Hatano T; Arai Y; Nishimura G; Hatakeyama H; Oridate N
    Anticancer Res; 2023 Jun; 43(6):2571-2582. PubMed ID: 37247900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolyl 4-hydroxylase subunit alpha 1 (P4HA1) is a biomarker of poor prognosis in primary melanomas, and its depletion inhibits melanoma cell invasion and disrupts tumor blood vessel walls.
    Eriksson J; Le Joncour V; Jahkola T; Juteau S; Laakkonen P; Saksela O; Hölttä E
    Mol Oncol; 2020 Apr; 14(4):742-762. PubMed ID: 32053263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prognostic value of faciogenital dysplasias as biomarkers in head and neck squamous cell carcinoma.
    Ma C; Li H; Li X; Lu S; He J
    Biomark Med; 2019 Nov; 13(16):1399-1415. PubMed ID: 31596126
    [No Abstract]   [Full Text] [Related]  

  • 13. FOXD1 expression in head and neck squamous carcinoma: a study based on TCGA, GEO and meta-analysis.
    Huang J; Liang B; Wang T
    Biosci Rep; 2021 Jul; 41(7):. PubMed ID: 34269372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Establishment of an immune-related gene prognostic model for head and neck tumors.
    Zhou F; Chen AX; Lv HY; Liang DH; Yu HS
    J Biol Regul Homeost Agents; 2021; 35(3):975-986. PubMed ID: 34159769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioinformatic analysis of PFN2 dysregulation and its prognostic value in head and neck squamous carcinoma.
    Liu J; Wu Y; Wang Q; Liu X; Liao X; Pan J
    Future Oncol; 2018 Feb; 14(5):449-459. PubMed ID: 29322815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative analysis of transcriptomics based hypoxia signatures in head- and neck squamous cell carcinoma.
    Tawk B; Schwager C; Deffaa O; Dyckhoff G; Warta R; Linge A; Krause M; Weichert W; Baumann M; Herold-Mende C; Debus J; Abdollahi A
    Radiother Oncol; 2016 Feb; 118(2):350-8. PubMed ID: 26711490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. P4HA1, a Prognostic Biomarker that Correlates With Immune Infiltrates in Lung Adenocarcinoma and Pan-Cancer.
    Zhao Q; Liu J
    Front Cell Dev Biol; 2021; 9():754580. PubMed ID: 34966739
    [No Abstract]   [Full Text] [Related]  

  • 18. P3H4 is correlated with clinicopathological features and prognosis in bladder cancer.
    Li W; Ye L; Chen Y; Chen P
    World J Surg Oncol; 2018 Oct; 16(1):206. PubMed ID: 30322400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of malignant T cell-amplified sequence 1 in head and neck squamous cell carcinoma.
    Zhu J; Wang X; Shao Z; Sun W; Wu T
    Biomark Med; 2021 Dec; 15(17):1623-1639. PubMed ID: 34704820
    [No Abstract]   [Full Text] [Related]  

  • 20. Spermine synthase (
    Pan X; Xue L; Sun Y
    Ann Transl Med; 2022 Nov; 10(22):1213. PubMed ID: 36544695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.